Valuation : Victrex plc

Market Cap 739M 998M 861M 811M 1.38B 94.32B 1.39B 9.61B 3.73B 48.22B 3.75B 3.67B 158B P/E 2026 *
-147x
P/E 2027 * 18.4x
Enterprise Value 781M 1.06B 910M 858M 1.46B 99.69B 1.47B 10.15B 3.94B 50.97B 3.96B 3.88B 167B EV / Sales 2026 *
2.62x
EV / Sales 2027 * 2.55x
Free-Float
99.14%
Yield 2026 *
7.02%
Yield 2027 * 7.02%
1 day+12.53%
3 months+12.53%
6 months+0.32%
Current year 3.8
Extreme 3.8
5.3
1 year 3.8
Extreme 3.8
5.3
3 years 3.8
Extreme 3.8
5.3
5 years 3.8
Extreme 3.8
5.3
10 years 3.8
Extreme 3.8
5.3
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO - -
Chief Operating Officer - 01/02/2025
Director TitleAgeSince
Director/Board Member 67 09/02/2018
Director/Board Member 70 09/02/2018
Director/Board Member 71 01/05/2020
Change 5-day change 1-year change 3-year change Capi.($)
+12.53%-.--% - - 991M
-0.12%-3.68%+1.86%+53.72% 78.56B
-1.06%-1.47%+1.24%-24.07% 37.48B
-1.54%-3.49%-5.51%+9.42% 37.03B
-3.24%+2.99%-5.67%+16.37% 25.83B
-0.31%+2.26%+29.73%+19.01% 22.9B
+0.78%+3.65%+87.00%+28.51% 23B
+0.62%-3.66%-41.54%-41.23% 17.84B
+1.63%+2.41%+73.18%-31.40% 15.99B
-0.65%-0.15%+10.79%-4.05% 14.65B
Average +0.93%+0.49%+16.79%+2.92% 30.37B
Weighted average by Cap. -0.41%-0.35%+11.38%+14.21%

Financials

2026 *2027 *
Net sales 299M 403M 348M 328M 558M 38.1B 562M 3.88B 1.51B 19.48B 1.51B 1.48B 63.98B 313M 422M 364M 343M 584M 39.89B 589M 4.06B 1.58B 20.39B 1.59B 1.55B 67B
Net income -4.01M -5.42M -4.67M -4.4M -7.5M -512M -7.55M -52.12M -20.23M -262M -20.34M -19.9M -859M 39.36M 53.15M 45.85M 43.19M 73.56M 5.02B 74.11M 511M 198M 2.57B 200M 195M 8.43B
Net Debt 42.11M 56.87M 49.06M 46.22M 78.71M 5.37B 79.3M 547M 212M 2.75B 214M 209M 9.02B 58.46M 78.95M 68.11M 64.16M 109M 7.46B 110M 760M 295M 3.81B 296M 290M 12.53B
Logo Victrex plc
Victrex plc is a United Kingdom‑based materials company. The Company manufactures and sells high‑performance polymers and polymer solutions. It develops polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based materials, and produces semi‑finished and finished components, including thermoplastic polymers, engineered parts and biomaterial solutions. It operates across Sustainable Solutions and Medical segments, addressing aerospace, automotive, energy, industrial, electronics and healthcare applications, and provides polymer processing, design support, and material innovation services for implantable and non‑implantable medical devices, as well as industrial and engineering uses. The Company's subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited, and Juvora Limited.
Employees
1,169
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
8.410GBP
Average target price
6.999GBP
Spread / Average Target
-16.77%

Quarterly revenue - Rate of surprise